Trial
NCT03237260
An Open Label Single-arm Phase 4 Study of Vedolizumab in Subjects With Newly Diagnosed Active Ulcerative Colitis
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
Takeda; Corporal Michael J. Crescenz VA Medical Center
Condition
Ulcerative Colitis
Intervention
Vedolizumab
Why stopped
No patient accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-08